BOLT vs IP · rev $7.7M vs P/E 43, $26.62B cap
Bolt Biotherapeutics (BOLT) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
IP does not have a complete income-statement cache yet.
BOLT currently screens at market cap $11.3M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the BOLT and IP stock pages for the full models.
Not investment advice.